期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

体外循环手术肺保护的研究进展

下载PDF
导出
摘要 在体外循环（CPB）手术后，肺部并发症是心脏手术后早期死亡的重要原因之一，据报道，CPB术后因肺部合并症死亡的患者约占CPB术后总死亡率的1／3。体外循环致肺损伤的机制目前尚不清楚，多数学者认为可能是血液暴露于人工仪器而引起的全身炎症反应、肺缺血一再灌注性损伤、肺表面活性物质减少所致。
作者 马中原 张玫 唐和年 张总刚 李明
机构地区 新疆维吾尔自治区人民医院心外科
出处 《新疆医学》 2011年第5期61-65,共5页 Xinjiang Medical Journal
关键词 体外循环手术 肺保护 术后早期死亡 肺表面活性物质 全身炎症反应 再灌注性损伤 肺部并发症 肺部合并症
分类号 R654.1 [医药卫生—外科学]
  • 相关文献

参考文献21

  • 1Sakurada T, Kazai T, Tanaka H, et al. Commparative experimental study of ceibral protectin during aortiC arch re - construction. Ann Thorac surg 1996161 : 1348 - 1354.
  • 2TanakaH. Experimental studyOn theoptimun flowrate andpressure for selective cerebral perfusion. Ann Thorac Surg,1995 ;59:651 -657.
  • 3Stahi R F, Fisher C A, KuciCh U, et al. Effects of stimulated extracorporeal circulation on human leukocyte elastase release superoxide generation and procoagulant activity[ J]. Thorac Cardiovasc Surg, 1991 ; 101:230 - 239.
  • 4Shafique T, Johnson R G, Dai H B, et al, Aletred pulmonary microvascular reactivity after total cardiopulmonary bypass [ J ]. J Cardiovasc Surg, 1993 ; 106:479 -486.
  • 5Mcgowan F X, Ikegami M, Del Midops, et al. Cardiopulmonarybypass Siginificantly reducessufactant activity in children[J]. J Thorac Cardiovasc Surg, 1993 ; 106:968 - 997.
  • 6Friedman M, Wang SY, Sellke FW, et al. Pulmonary in jury after total or partiai cardiopulmonary bypass with thromboxane synthesis inhibition,J. Ann Thorac Surg, 1995 ;59:598 - 603.
  • 7GU YJ, deVries A J, Boonstra PW, et al. Leukocyte depletion results in improved lung functionandreduced inflammatory response after cardiac sur - gery[ J]. J Thorac Cardiovasc Surg, 1996 ; 112:494 - 500.
  • 8苏俊武,闫作义,刘迎龙.体外循环中白细胞对肺损伤机制及白细胞过滤的肺保护作用[J].中国胸心血管外科临床杂志,2001,8(2):117-119. 被引量：6
  • 9胡俊,陈亦江,陈广明,朱秉智.抑肽酶对体外循环心脏手术血液系统及呼吸功能的保护作用[J].南京医科大学学报（自然科学版）,2002,22(4):328-330. 被引量：7
  • 10Liu LY, Wang Q, Zhu XD, et al. Pulmonary artary perfusion with pro - tective sohtion reduces injury after cardiophmonary bypass [ J ].Ann Thorac Surg,2000 ;69 : 1402 - 1407.

二级参考文献81

  • 1刘成玉,于维森.山莨菪碱对急性失血性休克家兔白细胞变形能力的影响[J].微循环学杂志,1995,5(2):8-10. 被引量：13
  • 2[1]Mohammad MH, Nicolas Gikakis, Shinji Miyamoto, et al. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass [J]. Ann Thorac Surg, 1999, 68: 473- 478.
  • 3[2]Osamashigeta, Hiroshi Kojima, Tomoaki Jikuya, et al. Aprotinin inhibits plasmin induced pletelet activation during cardiopulmonary bypass [J]. Circulation, 1997, 96(2): 569- 574.
  • 4[3]Dietrich W, Mossinger H, Spannagl M, et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations [J]. J Thorac Cardiovasc Surg, 1993, 105(4): 712- 720.
  • 5[4]Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass [J]. Ann Thorac Surg, 2001, 7(2): 745- 754.
  • 6[5]Landis RC, Asimakopoulos G, Poullis M, et al. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery [J]. Heart Surg Forum, 2001, 4 (suppl) 1: s35- 39.
  • 7[6]Asimakopoulos G, Lidington EA, Mason J, et al. Effect of aprotinin of endothelial cell activation [J]. J Thorac Cardiovasc Surg, 2001, 122(1): 123- 128.
  • 8[7]Rahman A, Ustunda B, Burma O, et al. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass[J]? Eur J Cardiothorac Surg, 2000, 18(5): 583- 588.
  • 9[1]Haslam PL,Baker CS,Hughes DA,et al.Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass:prophylactic use of surfactant therapy[J].Int J Exp Pathol,1997,78(4):277-289.
  • 10[2]LeVine AM, Lotze A, Stanley S,et al. Surfactant content in children with inflammatory lung disease[J].Crit Care Med,1996,24(6):1062-1067.

共引文献47

新疆医学
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部